Filtros de búsqueda

Lista de obras de

18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer

artículo científico publicado en 2010

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer

artículo científico publicado en 2003

A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma

artículo científico publicado en 2003

A Prospective Study of Bone Tumor Response Assessment in Metastatic Breast Cancer ⬇️

artículo científico publicado el 24 de octubre de 2012

A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression

artículo científico publicado en 2014

A delayed chemically induced tumorigenesis in Brca2 mutant mice

artículo científico publicado en 2004

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer

artículo científico publicado en 2002

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

artículo científico publicado en 2011

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach

artículo científico publicado en 2006

A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

scientific article published on 17 October 2011

A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer

artículo científico publicado en 2010

A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer

artículo científico publicado en 2010

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102.

artículo científico publicado en 2013

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338

artículo científico publicado en 2008

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β

artículo científico publicado en 2018

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer

artículo científico publicado en 2018

A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer

artículo científico publicado en 2010

AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model

artículo científico publicado en 2006

AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation

artículo científico publicado en 2016

Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer

artículo científico publicado en 2012

Accuracy of the BRCAPRO model among women with bilateral breast cancer

scientific article published on February 2009

Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.

artículo científico publicado en 2007

Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer

artículo científico publicado en 2010

Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells

artículo científico publicado en 2008

Acute Myeloid Leukemia After Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk

artículo científico publicado en 2007

Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial

artículo científico publicado en 2015

Adjuvant biologic therapy for breast cancer

artículo científico publicado en 2007

Adjuvant chemotherapy for breast cancer

artículo científico publicado en 2002

Adjuvant chemotherapy in early-stage breast cancer: what, when, and for whom?

artículo científico publicado en 2010

Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast

artículo científico publicado en 2007

Adjuvant systemic therapy for male breast carcinoma

artículo científico publicado en 2005

African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy

artículo científico publicado en 2006

Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype

artículo científico publicado en 2011

Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.

artículo científico publicado en 2009

An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.

artículo científico publicado en 2012

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

artículo científico publicado en 2010

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer

artículo científico publicado en 2009

Angiogenesis modulation in cancer research: novel clinical approaches

artículo científico publicado en 2002

Anthracycline regimen adherence in older patients with early breast cancer

artículo científico publicado en 2012

Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases

artículo científico publicado en 2015

Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1.

artículo científico publicado en 2006

Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?

artículo científico publicado en 2003

Aromatase inhibitors and breast cancer prevention ⬇️

artículo científico publicado el 14 de enero de 2012

Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients

artículo científico publicado en 2011

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

artículo científico publicado en 2002

Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer

artículo científico publicado en 2015

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

scientific article published on 29 January 2020

Automated electrorotation to reveal dielectric variations related to HER-2/neu overexpression in MCF-7 sublines.

artículo científico publicado en 2002

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

artículo científico publicado en 2011

BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment

artículo científico publicado en 2011

Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma

artículo científico publicado en 2006

Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer.

artículo científico publicado en 2011

Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.

artículo científico publicado en 2013

Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer

artículo científico publicado en 2020

Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

artículo científico publicado en 2016

Bone imaging in metastatic breast cancer

artículo científico publicado en 2004

Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status

artículo científico publicado en 2017

Brain metastases and breast cancer subtypes

artículo científico publicado en 2010

Breast Cancer Metastasis: Challenges and Opportunities

artículo científico publicado en 2009

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

artículo científico publicado en 2017

Breast cancer biomarkers and molecular medicine ⬇️

artículo científico publicado el 1 de septiembre de 2003

Breast cancer biomarkers and molecular medicine: part II.

artículo científico publicado en 2004

Breast cancer biomarkers.

artículo científico publicado en 2005

Breast cancer in men.

artículo científico publicado en 2002

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

artículo científico publicado en 2005

Breast cancer subtype and baseline characteristics from diabetic breast cancer patients are not different from nondiabetics.

artículo científico publicado en 2014

Breast cancer treatment guidelines in older women.

artículo científico publicado en 2005

Breast carcinoma in men: a population-based study

artículo científico publicado en 2004

Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States

artículo científico publicado en 2009

CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

scientific article published on 08 November 2019

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

CXCR4 expression in early breast cancer and risk of distant recurrence

artículo científico publicado en 2009

Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?

artículo científico publicado en 2008

Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer

artículo científico publicado en 2002

Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment

artículo científico publicado en 2020

Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

artículo científico publicado en 2008

Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer

artículo científico publicado en 2015

Cardiac morbidity of adjuvant radiotherapy for breast cancer.

artículo científico publicado en 2005

Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy

artículo científico publicado en 2003

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

artículo científico publicado en 2004

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

artículo científico publicado en 2004

Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival

artículo científico publicado en 2003

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

artículo científico publicado en 2009

Characterization of bone only metastasis patients with respect to tumor subtypes

artículo científico publicado en 2018

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update

scientific article published on 29 July 2021

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.

artículo científico

Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy

artículo científico publicado en 2003

Chest wall recurrence after mastectomy does not always portend a dismal outcome

scientific article published on 01 July 2003

Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?

artículo científico publicado en 2012

Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study

artículo científico publicado en 2019

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer

artículo científico publicado en 2016

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

artículo científico publicado en 2009

Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer

artículo científico publicado en 2010

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

artículo científico publicado en 2014

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

artículo científico publicado en 2014

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

artículo científico publicado en 2011

Circulating tumor cells in newly diagnosed inflammatory breast cancer

artículo científico publicado en 2015

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

artículo científico publicado en 2005

Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer

article

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

scientific article published on September 2008

Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival

artículo científico publicado en 2007

Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy

artículo científico publicado en 2008

Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines

artículo científico publicado en 2009

Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer

artículo científico publicado en 2014

Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients

artículo científico publicado en 2004

Colitis in patients with breast carcinoma treated with taxane-based chemotherapy

artículo científico publicado en 2004

Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways

artículo científico publicado en 2011

Combination anastrozole and fulvestrant in metastatic breast cancer

artículo científico publicado en 2012

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy

artículo científico publicado en 2007

Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors

artículo científico publicado en 2005

Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis

artículo científico

Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials

artículo científico publicado en 2007

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers

artículo científico publicado en 2013

Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips

artículo científico publicado en 2005

Completion of adjuvant radiation therapy among women with breast cancer

artículo científico publicado en 2008

Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study

artículo científico publicado en 2011

Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer

artículo científico publicado en 2012

Concomitant versus sequential chemotherapy in the treatment of early-stage and metastatic breast cancer.

artículo científico publicado en 2006

Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

scientific article published on 30 July 2007

Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial

artículo científico

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

artículo científico publicado en 2003

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2.

artículo científico

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

artículo científico publicado en 2015

Corrigendum: Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors.

artículo científico publicado en 2016

Current challenges of metastatic breast cancer.

artículo científico publicado en 2016

Cyclin E and survival in patients with breast cancer

artículo científico publicado en 2002

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

artículo científico publicado en 2016

DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design.

artículo científico publicado en 2006

Decline in the use of anthracyclines for breast cancer

artículo científico publicado en 2012

Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density

scientific article published on 25 February 2009

Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer

artículo científico publicado en 2014

Deubiquitination and Stabilization of PD-L1 by CSN5.

artículo científico publicado en 2016

Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer

artículo científico publicado en 2006

Development of CNS metastases and survival in patients with inflammatory breast cancer

article

Development of candidate genomic markers to select breast cancer patients for dasatinib therapy

artículo científico publicado en 2010

Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer

artículo científico publicado en 2005

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes

artículo científico publicado en 2013

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early

artículo científico publicado en 2010

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

artículo científico publicado en 2010

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

artículo científico publicado en 2013

Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers

artículo científico publicado en 2011

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

artículo científico publicado en 2013

Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase

artículo científico publicado en 2011

Ductal carcinoma in situ: state of the science and roadmap to advance the field

scientific article published on 08 December 2008

EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape

artículo científico publicado en 2016

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer

artículo científico publicado en 2017

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

artículo científico publicado en 2008

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling

artículo científico publicado en 2011

Earlier age of onset of BRCA mutation-related cancers in subsequent generations

artículo científico publicado en 2011

Early onset HER2‐positive breast cancer is associated with germline TP53 mutations ⬇️

artículo científico publicado el 14 de julio de 2011

Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer

artículo científico publicado en 2015

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer

artículo científico publicado en 2014

Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.

artículo científico publicado en 2013

Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer ⬇️

artículo científico publicado el 28 de julio de 2011

Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.

artículo científico publicado en 2008

Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor

artículo científico publicado en 2006

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

artículo científico publicado en 2010

Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 study

artículo científico publicado en 2013

Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer ⬇️

artículo científico publicado el 1 de septiembre de 2011

Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer

artículo científico publicado en 2014

Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence

artículo científico publicado en 2004

Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience

artículo científico publicado en 2007

Efficacy of anastrozole in male breast cancer

artículo científico publicado en 2002

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline‐ and nonanthracycline‐based regimens for HER2‐positive breast cancer ⬇️

artículo científico publicado el 27 de septiembre de 2011

Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer ⬇️

artículo científico publicado el 15 de diciembre de 2012

Emerging targeted therapies for breast cancer

artículo científico publicado en 2010

Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells

artículo científico publicado en 2006

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer

artículo científico publicado en 2022

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

artículo científico publicado en 2007

Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy

artículo científico publicado en 2005

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

artículo científico publicado en 2009

Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1

artículo científico publicado en 2012

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.

artículo científico publicado en 2018

Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.

artículo científico publicado en 2013

Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry

artículo científico publicado en 2012

Estrogen receptor expression and docetaxel efficacy in patients with metastatic breast cancer: a pooled analysis of four randomized trials.

artículo científico publicado en 2010

Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.

artículo científico publicado en 2008

Estrogen receptors and distinct patterns of breast cancer relapse

scientific article published on 01 March 2003

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer

artículo científico

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

artículo científico publicado en 2010

Evaluation of biological pathways involved in chemotherapy response in breast cancer

artículo científico publicado en 2008

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

artículo científico publicado en 2009

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

artículo científico publicado en 2002

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

artículo científico publicado en 2012

Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2.

artículo científico publicado en 2013

Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis

artículo científico publicado en 2013

Expression of BAG-1 and BcL-2 proteins before and after neoadjuvant chemotherapy of locally advanced breast cancer

artículo científico publicado en 2004

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

artículo científico publicado en 2011

FDG-PET/CT Compared with Conventional Imaging in the Detection of Distant Metastases of Primary Breast Cancer ⬇️

artículo científico publicado el 17 de julio de 2011

FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization

artículo científico publicado en 2011

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy

artículo científico publicado en 2005

Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases

artículo científico publicado en 2009

Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI.

artículo científico publicado en 2010

Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells

artículo científico publicado en 2010

Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer

scientific article published on 05 June 2006

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230

artículo científico publicado en 2019

Fingerprinting lymph node metastases

artículo científico publicado en 2008

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

artículo científico publicado en 2003

Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease

artículo científico publicado en 2002

Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer

artículo científico publicado en 2012

Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.

artículo científico publicado en 2016

Functional consequence of the MET-T1010I polymorphism in breast cancer

artículo científico publicado en 2015

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

artículo científico publicado en 2011

Future directions of bone-targeted therapy for metastatic breast cancer ⬇️

artículo científico publicado el 31 de agosto de 2010

Future of cancer incidence in the United States: burdens upon an aging, changing nation

artículo científico publicado en 2009

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt ⬇️

artículo científico publicado el 7 de agosto de 2011

Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer ⬇️

artículo científico publicado el 10 de enero de 2012

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

artículo científico publicado en 2005

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors

artículo científico publicado en 2003

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

artículo científico

Gene signature-guided dasatinib therapy in metastatic breast cancer.

artículo científico publicado en 2014

Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer

artículo científico publicado en 2013

Genomic grade index is associated with response to chemotherapy in patients with breast cancer

artículo científico publicado en 2009

Genomic index of sensitivity to endocrine therapy for breast cancer.

artículo científico publicado en 2010

Genotype inBRCA-associated Breast Cancers ⬇️

artículo científico publicado el 10 de diciembre de 2012

Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy

artículo científico publicado en 2010

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.

artículo científico publicado en 2016

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

artículo científico publicado en 2015

HER-2/neu testing in breast cancer

artículo científico publicado en 2003

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

artículo científico

HER2/neu in the management of invasive breast cancer

artículo científico publicado en 2002

Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy

artículo científico publicado en 2013

Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial

artículo científico publicado en 2013

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

artículo científico

Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.

artículo científico publicado en 2004

High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers

artículo científico publicado en 2009

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

artículo científico publicado en 2009

High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer

artículo científico publicado en 2014

High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients

artículo científico publicado en 2013

Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer

artículo científico publicado en 2010

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

artículo científico publicado en 2021

IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway

artículo científico publicado en 2007

Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis

artículo científico publicado en 2009

Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial

scholarly article by Xiaotong Li et al published 10 April 2019 in Journal for Immunotherapy of Cancer

Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer ⬇️

artículo científico publicado el 1 de abril de 2011

Impact of a scientific presentation on community treatment patterns for primary breast cancer

artículo científico publicado en 2006

Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy

artículo científico publicado en 2013

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer

scientific article published on 23 March 2009

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers ⬇️

artículo científico publicado el 11 de agosto de 2011

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

artículo científico publicado en 2011

Incidence of brain metastases as a first site of recurrence among women with triple receptor–negative breast cancer ⬇️

artículo científico publicado el 22 de febrero de 2012

Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice

artículo científico publicado en 2020

Indirect Evaluation of Bone Saturation with Zoledronic Acid After Long-Term Dosing

article

Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study

artículo científico publicado en 1991

Individualized care for patients with cancer - a work in progress

artículo científico publicado en 2004

Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

artículo científico publicado en 2007

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

artículo científico publicado en 2017

Inflammatory breast cancer: clinical progress and the main problems that must be addressed

artículo científico publicado en 2003

Inflammatory breast carcinoma: the sphinx of breast cancer research

artículo científico publicado en 2004

Initial Staging Impact of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast Cancer ⬇️

artículo científico publicado el 31 de mayo de 2011

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes ⬇️

artículo científico publicado el 18 de septiembre de 2012

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

artículo científico publicado en 2005

Is breast cancer survival improving?

artículo científico publicado en 2004

Ixabepilone for the treatment of breast cancer ⬇️

artículo científico publicado el 17 de mayo de 2011

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

artículo científico publicado en 2010

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

artículo científico publicado en 2012

Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.

artículo científico publicado en 2001

Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma

artículo científico publicado en 2004

Latest biopsy approach for suspected metastases in patients with breast cancer

artículo científico

Leptomeningeal disease and breast cancer: the importance of tumor subtype

artículo científico

Leuprolide Acetate Plus Aromatase Inhibition for Male Breast Cancer

scientific article published on 01 July 2006

Limits of observational data in determining outcomes from cancer therapy

artículo científico publicado en 2008

Local Recurrence or Cardiovascular Disease: Pay Now or Later

artículo científico publicado en 2007

Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment

artículo científico publicado en 2014

Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation

artículo científico publicado en 2003

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

artículo científico publicado en 2008

Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis

scientific article published on 01 February 2007

Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.

artículo científico publicado en 2002

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

artículo científico publicado en 2017

Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer

artículo científico publicado en 2019

Long-term complications associated with breast-conservation surgery and radiotherapy

scientific article published on 01 July 2002

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

artículo científico publicado en 2009

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors ⬇️

artículo científico publicado el 28 de noviembre de 2011

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

artículo científico publicado en 2008

Male breast cancer according to tumor subtype and race: a population-based study

artículo científico publicado en 2013

Mammography before diagnosis among women age 80 years and older with breast cancer

artículo científico publicado en 2008

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

artículo científico publicado en 2007

Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer

artículo científico publicado en 2006

Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer

artículo científico publicado en 2016

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

artículo científico publicado en 2009

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

artículo científico publicado en 2005

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

artículo científico publicado en 2010

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

artículo científico publicado en 2009

Molecular predictors of response to trastuzumab and lapatinib in breast cancer.

artículo científico publicado en 2009

Molecular prognostic factors for breast cancer metastasis and survival

artículo científico publicado en 2002

Molecular targets for treatment of inflammatory breast cancer

artículo científico publicado en 2009

Molecular therapeutics: promise and challenges

artículo científico publicado en 2004

Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer

artículo científico publicado en 2002

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer

artículo científico publicado en 2003

Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial

artículo científico publicado en 2011

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

artículo científico publicado en 2012

Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks

artículo científico publicado en 2003

Neoadjuvant chemotherapy for operable breast cancer

artículo científico publicado en 2002

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

artículo científico publicado en 2007

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer ⬇️

artículo científico publicado el 23 de mayo de 2011

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer

artículo científico publicado en 2010

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

artículo científico publicado en 2005

Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patient

artículo científico publicado en 2013

Novel pharmacological approaches in the treatment of breast cancer

artículo científico publicado en 2003

Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

artículo científico publicado en 2011

Nuclear factor-κB as a predictor of treatment response in breast cancer ⬇️

artículo científico publicado el 1 de noviembre de 2003

Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

artículo científico publicado en 2019

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

artículo científico publicado en 2011

Outcomes of children exposed in utero to chemotherapy for breast cancer

artículo científico publicado en 2014

Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma

artículo científico publicado en 2007

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

scientific article published on 01 March 2019

Overview of resistance to systemic therapy in patients with breast cancer

artículo científico publicado en 2007

Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle

artículo científico publicado en 2011

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression.

artículo científico publicado en 2017

PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase

artículo científico publicado en 2010

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.

artículo científico publicado en 2011

PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer

artículo científico publicado en 2008

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

artículo científico publicado en 2004

PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.

artículo científico publicado en 2010

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience

artículo científico publicado en 2004

Past, present, and future challenges in breast cancer treatment

artículo científico publicado en 2014

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity

artículo científico publicado en 2010

Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy

artículo científico publicado en 2002

Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation

artículo científico publicado en 2009

Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.

artículo científico publicado en 2017

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer

artículo científico publicado en 2006

Pharmacogenomics and clinical biomarkers in drug discovery and development

artículo científico publicado en 2005

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

artículo científico publicado en 2004

Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer

artículo científico publicado en 2008

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer

artículo científico publicado en 2003

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel

artículo científico publicado en 2002

Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer

artículo científico publicado en 2016

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

artículo científico publicado en 2006

Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma

artículo científico publicado en 2002

Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer

artículo científico publicado en 2002

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer

artículo científico publicado en 2012

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.

artículo científico publicado en 2008

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.

artículo científico publicado en 2011

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer

artículo científico publicado en 2015

Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622

artículo científico publicado en 2016

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

artículo científico publicado en 2010

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer

artículo científico publicado en 2002

Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer

artículo científico publicado en 2003

Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma

artículo científico publicado en 2005

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

artículo científico publicado en 2002

Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.

artículo científico publicado en 2012

Phase III Randomized Trial of Dose Intensive Neoadjuvant Chemotherapy with or Without G-CSF in Locally Advanced Breast Cancer: Long-Term Results ⬇️

artículo científico publicado el 31 de octubre de 2011

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer ⬇️

artículo científico publicado el 13 de febrero de 2012

Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0

artículo científico publicado el 10 de enero de 2011

Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.

artículo científico publicado en 2015

Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen

artículo científico publicado en 2004

Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer

artículo científico publicado en 2009

Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases

artículo científico publicado en 2013

Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression

artículo científico publicado en 2017

Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy

artículo científico publicado en 2004

Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy

artículo científico publicado en 2007

Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.

artículo científico publicado en 2007

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells

artículo científico publicado en 2009

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ ⬇️

artículo científico publicado el 25 de agosto de 2011

Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation

artículo científico publicado en 2002

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy

artículo científico publicado en 2005

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer

artículo científico publicado en 2010

Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing

artículo científico publicado en 2014

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

artículo científico publicado en 2008

Primary angiosarcomas of the breast

artículo científico publicado en 2007

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype

artículo científico publicado en 2011

Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.

artículo científico publicado en 2002

Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival

artículo científico publicado en 2013

Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer

artículo científico publicado en 2014

Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer

artículo científico publicado en 2002

Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, PA.

artículo científico publicado en 2004

Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature

artículo científico publicado en 2006

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

artículo científico publicado en 2009

Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer ⬇️

artículo científico publicado el 28 de junio de 2011

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2012

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

artículo científico publicado en 2010

Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer

artículo científico publicado en 2010

Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review

artículo científico publicado en 2010

Prognostic molecular markers in early breast cancer

artículo científico publicado en 2004

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

artículo científico publicado en 2005

Prognostic significance of HER-2 status in women with inflammatory breast cancer

artículo científico publicado en 2008

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma

artículo científico publicado en 2004

Prognostic value of body mass index in locally advanced breast cancer

artículo científico publicado en 2008

Prognostic value of nodal ratios in node-positive breast cancer

artículo científico publicado en 2006

Prognostic value of nodal ratios in node-positive breast cancer: a compiled update.

artículo científico publicado en 2009

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

artículo científico publicado en 2006

Progress against solid tumors in danger: the metastatic breast cancer example

artículo científico publicado en 2012

Promoting quality and evidence-based care in early-stage breast cancer follow-up

artículo científico publicado en 2014

Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes

artículo científico publicado en 2008

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

artículo científico publicado en 2003

Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

artículo científico publicado en 2014

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation

artículo científico publicado en 2010

Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization

artículo científico publicado en 2009

Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy

artículo científico publicado en 2009

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

artículo científico publicado en 2006

Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy

artículo científico publicado en 2015

Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer

artículo científico publicado en 2012

Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.

artículo científico publicado en 2008

Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

scientific article published on 18 July 2019

Reply to F.-C. Bidard et al.

artículo científico publicado en 2015

Reply to S. Mahesh

artículo científico

Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience ⬇️

artículo científico publicado el 6 de septiembre de 2011

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

artículo científico publicado en 2008

Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone‐only metastases ⬇️

artículo científico publicado el 2 de diciembre de 2011

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes

artículo científico publicado en 2017

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

artículo científico publicado en 2016

Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.

artículo científico publicado en 2017

Risk of cardiac death after adjuvant radiotherapy for breast cancer

artículo científico publicado en 2005

Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer

artículo científico publicado en 2014

Role of anthracyclines in the treatment of early breast cancer

artículo científico publicado en 2009

Role of epidermal growth factor receptor in breast cancer

artículo científico publicado en 2012

SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer ⬇️

artículo científico publicado el 9 de agosto de 2011

Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.

artículo científico publicado en 2013

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).

artículo científico publicado en 2010

Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer ⬇️

artículo científico publicado el 12 de agosto de 2011

Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity

artículo científico publicado en 2007

Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer

artículo científico publicado en 2003

Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer

artículo científico publicado en 2011

Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer

artículo científico publicado en 2016

Signal transduction inhibitors in the treatment of breast cancer.

artículo científico publicado en 2003

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

artículo científico publicado en 2005

Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer

artículo científico publicado en 2010

Squamous Cell Carcinoma of the Breast

artículo científico publicado en 2005

Staging of breast cancer in the neoadjuvant setting

artículo científico publicado en 2008

Standardizing Slide-Based Assays in Breast Cancer: Hormone Receptors, HER2, and Sentinel Lymph Nodes

artículo científico publicado en 2007

Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke

artículo científico publicado en 2006

Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells

artículo científico publicado en 2019

T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy

artículo científico publicado en 2004

TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis.

artículo científico publicado en 2016

TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.

artículo científico publicado en 2013

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

artículo científico publicado en 2014

Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model

artículo científico publicado en 2003

Targeted therapies for cancer 2004.

artículo científico publicado en 2004

Targeted therapy in breast cancer: the HER-2/neu gene and protein

artículo científico publicado en 2004

Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model

artículo científico publicado en 2010

Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer.

artículo científico publicado en 2012

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

artículo científico publicado en 2015

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

scientific article published on 03 April 2009

The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment

artículo científico publicado en 2016

The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells.

artículo científico publicado en 2015

The global breast cancer burden: variations in epidemiology and survival.

artículo científico publicado en 2005

The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study

artículo científico publicado en 2005

The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.

artículo científico publicado en 2005

The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial

artículo científico publicado en 2004

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy

artículo científico publicado en 2004

Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer

artículo científico publicado en 2007

Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial

artículo científico publicado en 2018

Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma

artículo científico publicado en 2005

Time to remove the subspecialty blinders: breast cancer does not exist in isolation

artículo científico publicado en 2008

Timing of surgical intervention for the intact primary in stage IV breast cancer patients

scientific article published on 21 March 2008

Topoisomerase II{alpha} amplification and anthracycline-based chemotherapy: the jury is still out.

artículo científico publicado en 2009

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma

artículo científico publicado en 2003

Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes

artículo científico publicado en 2016

Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer

artículo científico publicado en 2002

Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome

artículo científico publicado en 2010

Trastuzumab-related cardiotoxicity among older patients with breast cancer

artículo científico publicado en 2013

Treatment Outcome and Prognostic Factors for Patients with Bone-Only Metastases of Breast Cancer: A Single-Institution Retrospective Analysis ⬇️

artículo científico publicado el 25 de enero de 2011

Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.

artículo científico publicado en 2006

Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer

artículo científico publicado en 2008

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes

artículo científico publicado en 2008

Two good choices to prevent breast cancer: great taste, less filling

artículo científico publicado en 2010

USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer

artículo científico publicado en 2013

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

artículo científico publicado en 2004

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

scientific article published on 01 June 2006

Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes

artículo científico publicado en 2013

Use of intravenous bisphosphonates in older women with breast cancer

artículo científico publicado en 2008

Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer

artículo científico publicado en 2008

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancers ⬇️

artículo científico publicado el 15 de noviembre de 2010

Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer

artículo científico publicado en 2017

Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy

artículo científico publicado en 2011

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

artículo científico publicado en 2005

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

artículo científico publicado en 2005

Wound complications from surgery in pregnancy-associated breast cancer (PABC).

artículo científico publicado en 2010

Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer-Reply

artículo científico publicado en 2017

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer

artículo científico publicado en 2014

cMET and phospho-cMET protein levels in breast cancers and survival outcomes

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda